A detailed history of Israel Englander (Millennium Management LLC) transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Millennium Management LLC holds 606,039 shares of PCRX stock, worth $11.8 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
606,039
Previous 25,000 2324.16%
Holding current value
$11.8 Million
Previous $715,000 1176.36%
% of portfolio
0.0%
Previous 0.0%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$11.7 - $28.46 $7.09 Million - $17.2 Million
606,039 New
606,039 $9.13 Million
Q1 2024

May 15, 2024

BUY
$27.7 - $35.48 $1.04 Million - $1.33 Million
37,448 New
37,448 $1.09 Million
Q2 2023

Aug 14, 2023

SELL
$36.12 - $47.5 $57 Million - $75 Million
-1,578,969 Reduced 99.51%
7,774 $311,000
Q1 2023

May 15, 2023

BUY
$35.53 - $43.38 $15.5 Million - $18.9 Million
434,989 Added 37.77%
1,586,743 $64.8 Million
Q4 2022

Feb 14, 2023

BUY
$38.19 - $57.45 $26.1 Million - $39.3 Million
683,680 Added 146.06%
1,151,754 $44.5 Million
Q3 2022

Nov 14, 2022

BUY
$51.24 - $58.89 $22.4 Million - $25.7 Million
436,699 Added 1391.87%
468,074 $24.9 Million
Q2 2022

Aug 15, 2022

BUY
$51.49 - $81.64 $1.62 Million - $2.56 Million
31,375 New
31,375 $1.83 Million
Q1 2022

May 16, 2022

SELL
$60.03 - $76.49 $7.95 Million - $10.1 Million
-132,483 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$47.97 - $62.21 $3.05 Million - $3.96 Million
63,661 Added 92.5%
132,483 $7.97 Million
Q3 2021

Nov 15, 2021

SELL
$54.64 - $61.3 $4.3 Million - $4.83 Million
-78,765 Reduced 53.37%
68,822 $3.85 Million
Q2 2021

Aug 16, 2021

BUY
$59.18 - $69.99 $1.97 Million - $2.33 Million
33,247 Added 29.08%
147,587 $8.96 Million
Q1 2021

May 17, 2021

BUY
$59.31 - $78.82 $1.68 Million - $2.24 Million
28,356 Added 32.98%
114,340 $8.01 Million
Q4 2020

Feb 16, 2021

BUY
$50.47 - $66.26 $100,687 - $132,188
1,995 Added 2.38%
85,984 $5.15 Million
Q3 2020

Nov 16, 2020

BUY
$51.97 - $63.0 $4.16 Million - $5.04 Million
80,059 Added 2037.12%
83,989 $5.05 Million
Q2 2020

Aug 14, 2020

SELL
$30.8 - $52.47 $5.07 Million - $8.63 Million
-164,524 Reduced 97.67%
3,930 $206,000
Q1 2020

May 14, 2020

SELL
$28.4 - $50.7 $3.36 Million - $5.99 Million
-118,226 Reduced 41.24%
168,454 $5.65 Million
Q4 2019

Feb 14, 2020

SELL
$36.31 - $46.83 $12.8 Million - $16.5 Million
-352,459 Reduced 55.15%
286,680 $13 Million
Q3 2019

Nov 14, 2019

SELL
$35.66 - $44.99 $30.1 Million - $38 Million
-844,598 Reduced 56.92%
639,139 $24.3 Million
Q2 2019

Aug 14, 2019

BUY
$36.57 - $47.97 $14.3 Million - $18.7 Million
390,034 Added 35.66%
1,483,737 $64.5 Million
Q1 2019

May 14, 2019

SELL
$36.47 - $42.17 $4.77 Million - $5.52 Million
-130,811 Reduced 10.68%
1,093,703 $41.6 Million
Q4 2018

Feb 14, 2019

SELL
$41.31 - $52.16 $8.45 Million - $10.7 Million
-204,456 Reduced 14.31%
1,224,514 $52.7 Million
Q3 2018

Nov 14, 2018

BUY
$32.85 - $52.0 $12.4 Million - $19.6 Million
376,467 Added 35.77%
1,428,970 $70.2 Million
Q2 2018

Aug 14, 2018

BUY
$27.5 - $39.8 $4.51 Million - $6.53 Million
164,112 Added 18.47%
1,052,503 $33.7 Million
Q1 2018

May 15, 2018

BUY
$29.98 - $46.35 $10.4 Million - $16.2 Million
348,542 Added 64.56%
888,391 $27.7 Million
Q4 2017

Feb 14, 2018

BUY
$31.85 - $46.95 $17.2 Million - $25.3 Million
539,849
539,849 $24.6 Million

Others Institutions Holding PCRX

About Pacira BioSciences, Inc.


  • Ticker PCRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 45,824,200
  • Market Cap $892M
  • Description
  • Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...
More about PCRX
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.